A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

NCT06493461 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's Decision

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

BIOLOGICAL: HS135

Sponsor

35Pharma Inc